Product Code: RP-ID-10346972 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10346972
Market Overview:
Global Diagnostic Specialty Antibodies Market Size study, by Type (Monoclonal Antibodies, Polyclonal Antibodies, Others), by Application (Oncology Diagnosis, Hepatitis Diagnosis, Infectious Disease Diagnosis, Others), by End-User (Diagnostic Laboratories, Hospitals) and Regional Forecasts 2020-2027
Market Overview
Global Diagnostic Specialty Antibodies Market is valued at approximately USD 19.6 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 3.0% over the forecast period 2020-2027. Antibodies are the part of blood proteins that produced in response to a certain antigen. They are usually known as immunoglobulin and are generally in the shape of the Y structure. These antibodies are effectual and increase the binding capacity of any sort of certain antigen. Further, the advancements in technology, particularly in the genetic engineering field help introduce numerous antibodies, that are frequently monoclonal antibodies. These are additionally effectual and robust that can help in the betterment of the capacity of binding to an antigen. Also, these antibodies have demonstrated to be effective as diagnostic tools for the assessment and testing of numerous infectious diseases. Thus, the rise in prevalence of infectious, such as HIV/AIDS, along with growing R&D expenditure in the pharmaceutical and biopharmaceutical companies are the few factors responsible for the CAGR of the market during the forecast period. According to the Avert organization, roughly 37.9 million individuals were affected by HIV (including 1.7 million children) in 2018, with a global HIV prevalence of 0.8% in the adult population. Similarly, the U.S. Department of Health & Human Services estimated that about 21.7 million people living with HIV in 2017, representing an increase of 2.3 million from 2016 and 8 million since 2010. This, in turn, is expected to strengthen the market growth all over the world. In addition, the demand for diagnostic specialty antibodies has decreased recently due to the concerns faced considering antibodies that are not capable to operate a precise and smooth diagnostic test for regular diagnosis, which may limit the market growth around the world. However, the high cost of the development of diagnostic specialty antibodies is one of the major factors restraining market growth over the forecast period of 2020-2027.
The regional analysis of the global Diagnostic Specialty Antibodies market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rise in prevalence of infectious diseases and life-threatening diseases, along with the significant presence of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in pharmaceutical and biopharmaceutical expenditure, along with the rise in government programs concerning diseases treatment and improving healthcare infrastructure in developing countries, such as China and India, would create lucrative growth prospects for the Diagnostic Specialty Antibodies market across the Asia-Pacific region.
Major market player included in this report are:
F. Hoffmann-La Roche AG
Abbott Laboratories
Abcam plc
Bio-Rad Laboratories, Inc.
Agilent Technologies, Inc.
Creative Diagnostics
Thermo Fisher Scientific Inc.
Becton, Dickinson and Company
Merck KGaA
Sartorius AG
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Monoclonal Antibodies
Polyclonal Antibodies
Others
By Application:
Oncology Diagnosis
Hepatitis Diagnosis
Infectious Disease Diagnosis
Others
By End-User:
Diagnostic Laboratories
Hospitals
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027
Target Audience of the Global Diagnostic Specialty Antibodies Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
F. Hoffmann-La Roche AG
Abbott Laboratories
Abcam plc
Bio-Rad Laboratories, Inc.
Agilent Technologies, Inc.
Creative Diagnostics
Thermo Fisher Scientific Inc.
Becton, Dickinson and Company
Merck KGaA
Sartorius AG
Related Reports
Proof of Quality & Reliability
